ArticlePharmacology research & perspectives2022

Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy.

Li Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.